The Fountain Stack (CJC-1295 + Ipamorelin)

This stack leverages the concept of 'Dual-Pathway Stimulation' to maximize endogenous Growth Hormone (GH) production while maintaining physiological safety. 1. CJC-1295 No DAC (The Amplifier): Acts on the GHRH receptor in the pituitary gland. It increases the *volume* of GH released per pulse but cannot initiate the pulse effectively on its own. 2. Ipamorelin (The Initiator): Acts on the Ghrelin receptor (GHSR-1a). It creates a sharp *initiation* signal for a GH pulse and suppresses somatostatin (the hormone that blocks GH). Synergy: When administered together, they create a non-linear 'multiplying effect.' Ipamorelin starts the pulse and removes the 'brake' (somatostatin), allowing CJC-1295 to maximize the 'gas' (GHRH). Clinical data suggests this combination releases 5x more GH than either agent alone. Furthermore, because both are selective, they do not trigger cortisol (stress) or prolactin, avoiding the water retention and moodiness associated with older generation peptides.